1-6 of 6
Donald Edward Tsai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes in Primary CNS Lymphoma: A Single Institution Experience from the Abramson Cancer Center at the University of Pennsylvania

Nikita Dave, Veronica Carvajal, Jordan Carter, Donald Edward Tsai, Stephen J. Schuster, James Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta
Journal: Blood
Blood (2024) 144 (Supplement 1): 1699.
https://doi.org/10.1182/blood-2024-207781
Published: 2024
Journal Articles

Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL)

Mitchell E. Hughes, PharmD, Daniel J. Landsburg, MD, Daniel J Rubin, PharmD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Donald Edward Tsai, MD PhD, Kyle Robinson, MD, Saar I. Gill, MDPhD, Anthony R. Mato, MDMSCE, James Nathan Gerson, MD, Danielle Land, CRNP, Brenda Shelly, CRNP, Alicia McLeish, CRNP, Allison Rago, CRNP, Jennifer Gill, CRNP, Kristy Walsh, BS, Tanya Latorre, RN, Jessica K. Altman, MD, Colleen Timlin, PharmD, Donna Capozzi, PharmD, BCOP, Sunita Dwivedy Nasta, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1706.
https://doi.org/10.1182/blood-2018-99-111194
Published: 2018
Journal Articles

Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder

Susan Prockop, MD, Ai Li, PhD, Robert A Baiocchi, MD PhD, Nancy Bunin, MD, Kris Michael Mahadeo, MD, Eneida R. Nemecek, MD, Sarah Nikiforow, MD PhD, Ran Reshef, MD, Donald Edward Tsai, MD PhD, Willis H. Navarro, MD, Richard J. O'Reilly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4520.
https://doi.org/10.1182/blood.V130.Suppl_1.4520.4520
Published: 2017
Journal Articles

The Changing Face of Adult Posttransplant Lymphoproliferative Disorder: Dramatic Changes in Histology between 1999-2013

Donald Edward Tsai, MD PhD, Scott Huntington, MDMPH, Ran Reshef, MDMSc, Abraham Shaked, MD, Roy Bloom, MD, Vivek Ahya, Lee Goldberg, MD, Albert Chung, Fotini Debonera, Stephen J. Schuster, MD, Stephen Joseph Bagley, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1574.
https://doi.org/10.1182/blood.V130.Suppl_1.1574.1574
Published: 2017
Journal Articles

Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas

Mitchell E. Hughes, PharmD, BCPS, BCOP, Christopher Jensen, MD, Jakub Svoboda, MD, Lauren Elizabeth Strelec, BA, Matthew R. Youngman, BS, Stephen J. Schuster, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Donald Edward Tsai, MD PhD, David Michael Mintzer, MD, Jennifer Gill, NP, MSN, Colleen Dorsey, BSN, Kaitlin Kennard, RN, BSN, Elizabeth T Chatburn, BS, Joanna Rhodes, MD, Krista Isaac, DO, MS, Kristy Walsh, BS, Tanya Latorre, BSN, RN, Kaley Piersanti, BS, Evan Bannister, BS, Colleen Timlin, PharmD, BCOP, Donna Capozzi, PharmD, BCOP, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1575.
https://doi.org/10.1182/blood.V130.Suppl_1.1575.1575
Published: 2017
Journal Articles

Long Term Outcomes of Rituximab, Temozolamide, and High-Dose Methotrexate for Lymphoma Involving the Central Nervous System

Sarah Jordan Nagle, MD, Nirav N. Shah, MD, Alex Ganetsky, PharmD, BCOP, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Anthony Mato, MD, Stephen J. Schuster, MD, Donald Edward Tsai, MD PhD, Jakub Svoboda, MD
Journal: Blood
Blood (2015) 126 (23): 2701.
https://doi.org/10.1182/blood.V126.23.2701.2701
Published: 2015